North America Embolotherapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

No. of Pages: 169    |    Report Code: BMIRE00027551    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Embolotherapy Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Embolotherapy Market – by Product

1.3.2        North America Embolotherapy Market – by Disease Indication

1.3.3        North America Embolotherapy Market – by Procedure

1.3.4        North America Embolotherapy Market – by End User

1.3.5        North America Embolotherapy Market– By Country

2.           North America Embolotherapy Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Embolotherapy Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           North America Embolotherapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Burgeoning Incidence of Cancer Cases

5.1.2        Boosting Patient Preference for Minimally Invasive Procedures

5.2         Market Restraints

5.2.1        Availability of Other Alternative Therapies

5.3         Market Opportunity

5.3.1        Elevating Applications of Embolotherapy

5.4         Market Trend

5.4.1        Widening Use of Liquid Embolic Agents

5.5         Impact analysis

6.           North America Embolotherapy Market Analysis

6.1         North America Embolotherapy Market Revenue Forecast and Analysis

7.           North America Embolotherapy Market – by Product

7.1         Overview

7.2         North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3         Embolic Agents

7.3.1        Overview

7.3.2        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3        Microspheres

7.3.3.1          Overview

7.3.3.2          Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4        Embolic Coils

7.3.4.1          Overview

7.3.4.2          Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5        Embolic Plug Systems

7.3.5.1          Overview

7.3.5.2          Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6        Detachable Balloons

7.3.6.1          Overview

7.3.6.2          Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7        Liquid Embolic Agents

7.3.7.1          Overview

7.3.7.2          Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8        Others

7.3.8.1          Overview

7.3.8.2          Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Support Devices

7.4.1        Overview

7.4.2        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3        Microcatheters

7.4.3.1          Overview

7.4.3.2          Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4        Guidewires

7.4.4.1          Overview

7.4.4.2          Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8.           North America Embolotherapy Market Analysis – by Disease Indication

8.1         Overview

8.2         North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3         Cancer

8.3.1        Overview

8.3.2        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Liver Cancer

8.3.2.1.1          Overview

8.3.2.1.2          Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Kidney Cancer

8.3.2.2.1          Overview

8.3.2.2.2          Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Other Cancers

8.3.2.3.1          Overview

8.3.2.3.2          Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Peripheral Vascular Diseases

8.4.1        Overview

8.4.2        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurological Diseases

8.5.1        Overview

8.5.2        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Urological and Nephrological Disorders

8.6.1        Overview

8.6.2        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Gastrointestinal Disorders

8.7.1        Overview

8.7.2        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Embolotherapy Market Analysis – by Procedure

9.1         Overview

9.2         North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3         Transcatheter Arterial Embolization (TAE)

9.3.1        Overview

9.3.2        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1        Overview

9.4.2        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Transarterial Chemoembolization (TACE)

9.5.1        Overview

9.5.2        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Embolotherapy Market Analysis – By End User

10.1      Overview

10.2      North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Other End Users

10.5.1     Overview

10.5.2     Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Embolotherapy Market – Country Analysis

11.1      North America Embolotherapy Market

11.1.1     North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.1.1       US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2       US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.1    US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.2    US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.1    US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4       US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5       US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2       Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2       Canada Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.1    Canada Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.2    Canada Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Canada Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3.1    Canada Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4       Canada Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5       Canada Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3       Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2       Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.1    Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.2    Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.1    Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4       Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5       Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

12.        Embolotherapy Market –Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott Laboratories

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Boston Scientific Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Cook Medical LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Johnson & Johnson

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Medtronic

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Acandis GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Balt USA LLC

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Stryker Corporation

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Guerbet LLC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Terumo Corporation

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7.             US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)

Table 14.          Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 22.          Organic Developments Done by Companies

Table 23.          Inorganic Developments Done by Companies

Table 24.          Glossary of Terms, North America Embolotherapy Market

 

 

LIST OF FIGURES

Figure 1.           North America Embolotherapy Market Segmentation

Figure 2.           North America Embolotherapy Market, By Country

Figure 3.           North America Embolotherapy Market Overview

Figure 4.           Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market

Figure 5.           Embolotherapy Market in North America to Show Remarkable Growth During Forecast Period

Figure 6.           North America Embolotherapy Market, Industry Landscape

Figure 7.           North America PEST Analysis

Figure 8.           North America Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11.        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22.        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32.        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36.        Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        North America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40.        North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

Figure 41.        US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - North America Embolotherapy Market

  1. Abbott Laboratories
  2. Boston Scientific Corporation
  3. Cook Medical LLC        
  4. Johnson & Johnson
  5. Medtronic
  6. Acandis GmbH  
  7. Balt USA LLC
  8. Stryker Corporation
  9. Guerbet LLC
  10. Terumo Corporation